Ozempics maker, Novo Nordisk, managed to make an oral version of semaglutide by adding an ingredient called SNAC, which acts as an absorption enhancer
Multiple sclerosis An autoimmune disease in which the immune system mistakenly attacks healthy cells that produce myelin, causing damage to nerve fibres in the central nervous system and disrupting the transmission of nerve signals
Weight loss efficacy When used in combination (CagriSema), the weight loss effect appears to be additive, potentially offering superior results to either medication alone
Treatment is then tailored to the individual and the specific characteristics of the cancer
Ozempic, Wegovy, and Rybelsus are all part of the same drug class and are involved in ongoing litigation regarding their potential side effects
They are not for human consumption, medical use, veterinary use, therapeutic use, diagnostic use, or clinical application